Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for succinylcholine-related sore throat, myalgia, and fasciculation in appendectomy
IRCT20190528043737N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of lidocaine and succinylcholine in Post-extubation sore throat (POST) and myalgia (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Rate of fasciculation, Severity of sore throat and 1 more. Started Oct 2017; status: completed.
02
Drugs
lidocainesuccinylcholine
03
Conditions
Post-extubation sore throat (POST)myalgia
Beyond the preview
Go deeper on IRCT20190528043737N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190528043737N1.